BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16323393)

  • 1. 5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting.
    Chiou KR; Chung SL; Charng MJ
    J Chin Med Assoc; 2005 Nov; 68(11):506-12. PubMed ID: 16323393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.
    Hoppmann P; Koch W; Schömig A; Kastrati A
    Eur Heart J; 2004 Feb; 25(4):335-41. PubMed ID: 14984923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
    Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
    Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between smoking and the stromelysin-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men.
    Humphries SE; Martin S; Cooper J; Miller G
    Ann Hum Genet; 2002 Nov; 66(Pt 5-6):343-52. PubMed ID: 12485468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
    Kim JS; Park HY; Kwon JH; Im EK; Choi DH; Jang YS; Cho SY
    Yonsei Med J; 2002 Aug; 43(4):473-81. PubMed ID: 12205736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B12 is associated with coronary in-stent restenosis.
    Chung SL; Chiou KR; Charng MJ
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):349-55. PubMed ID: 16489563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis.
    de Maat MP; Jukema JW; Ye S; Zwinderman AH; Moghaddam PH; Beekman M; Kastelein JJ; van Boven AJ; Bruschke AV; Humphries SE; Kluft C; Henney AM
    Am J Cardiol; 1999 Mar; 83(6):852-6. PubMed ID: 10190398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.
    Humphries SE; Luong LA; Talmud PJ; Frick MH; Kesäniemi YA; Pasternack A; Taskinen MR; Syvänne M
    Atherosclerosis; 1998 Jul; 139(1):49-56. PubMed ID: 9699891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease.
    Schwarz A; Haberbosch W; Tillmanns H; Gardemann A
    Dis Markers; 2002; 18(3):121-8. PubMed ID: 12515907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Gene Polymorphisms/Haplotypes and Plasma Level of TGF-β1 in Susceptibility to In-Stent Restenosis Following Coronary Implantation of Bare Metal Stent in Chinese Han Patients.
    Chen HJ; Mo N; Zhang YF; Su GZ; Wu HD; Pei F
    Int Heart J; 2018 Jan; 59(1):161-169. PubMed ID: 29332922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.
    Ye S; Watts GF; Mandalia S; Humphries SE; Henney AM
    Br Heart J; 1995 Mar; 73(3):209-15. PubMed ID: 7727178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
    Zeng WP; Zhang R; Li R; Luo JF; Hu XF
    PLoS One; 2017; 12(1):e0170964. PubMed ID: 28129392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene.
    Takahashi M; Haro H; Wakabayashi Y; Kawa-uchi T; Komori H; Shinomiya K
    J Bone Joint Surg Br; 2001 May; 83(4):491-5. PubMed ID: 11380116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
    Liu PY; Chen JH; Li YH; Wu HL; Shi GY
    Thromb Haemost; 2003 Jul; 90(1):132-9. PubMed ID: 12876636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of matrix metalloproteinase 3 5A/6A polymorphism with in-stent restenosis after percutaneous coronary interventions in a Han Chinese population.
    Du JB; Zhang W; Li N; Jiang H; Liu Y; Gao J; Chen ST; Cong HL; Wei YL
    J Int Med Res; 2020 Jan; 48(1):300060519827145. PubMed ID: 30732526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis.
    Gomma AH; Elrayess MA; Knight CJ; Hawe E; Fox KM; Humphries SE
    Eur Heart J; 2002 Dec; 23(24):1955-62. PubMed ID: 12473258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects.
    Gnasso A; Motti C; Irace C; Carallo C; Liberatoscioli L; Bernardini S; Massoud R; Mattioli PL; Federici G; Cortese C
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1600-5. PubMed ID: 10845878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.